AegirBio
The Disciplinary Committee of Nasdaq Stockholm has resolved that AegirBio shall pay fees
REG
The resolution means that the agreement with Atlas Special Opportunities, LLC regarding convertibles amounting to MSEK 55 with attached warrants, which was made public on 20 December 2022, will be fulfilled in accordance with its terms and conditions.
"AegirBio has been informed that the Disciplinary Committee of Nasdaq Stockholm has resolved to not delist AegirBio and instead order the company to pay fees. In our opinion, it is the correct resolution to not comply with Nasdaq Stockholm's request for delisting. The company is hereby putting a highly turbulent time behind it and is looking forward to focusing on its core business", says Bradley Messmer, CEO of AegirBio.
| Datum | 2023-03-14, kl 08:39 |
| Källa | Cision |
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.